NON-DESTRUCTIVE EVALUATION OF WIRE INSULATION AND COATINGS

Details for Australian Patent Application No. 2002326488 (hide)

Owner THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL

Inventors Not Given

Pub. Number AU-A-2002326488

PCT Number PCT/US02/24321

PCT Pub. Number WO2003/012425

Priority Not Given 24.04.02 US; 60/311,967 01.08.01 US; Not Given 24.04.02 US; 60/396,498 17.07.02 US; 60/396,498 17.07.02 US; 60/311,967 01.08.01 US

Filing date 1 August 2002

Wipo publication date 17 February 2003

International Classifications

G01N 029/18 Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves

G01N 029/18 Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): Not Given 24.04.02 US; 60/311,967 01.08.01 US; Not Given 24.04.02 US; 60/396,498 17.07.02 US; 60/396,498 17.07.02 US; 60/311,967 01.08.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002326488

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002326489-SYSTEMS AND METHOD FOR MULTICARRIER MODULATION USING MULTI-TAP FREQUENCY-DOMAIN EQUALIZER AND DECISION FEEDBACK

2002326487-SULFONAMIDE DERIVATIVES AS GAMMA SECRETASE INHIBITORS